Quantitative structure activity relationships in drug metabolism

被引:28
作者
Chohan, Kamaldeep K. [1 ]
Paine, Stuart W. [1 ]
Waters, Nigel J. [1 ]
机构
[1] AstraZeneca R&D Charnwood, Dept Phys & Metab Sci, Loughborough LE11 5RH, Leics, England
关键词
D O I
10.2174/156802606778108960
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
This review of 61 references delineates contemporary computation quantitative structure activity relationship (QSAR) approaches that have been used to elucidate the molecular features that influence the binding and metabolism of a compound by the major phase I and phase 2 metabolising enzymes; Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT), respectively. Contemporary studies are applying 2D and 3D QSAR, pharmacophore approaches and nonlinear techniques (for example: recursive partitioning, neural networks and support vector machines) to model drug metabolism. Furthermore, this review highlights some of the challenges and opportunities for future research; the need to develop 'global' models for CYP and UGT metabolism and to extend QSAR for other important metabolising enzymes.
引用
收藏
页码:1569 / 1578
页数:10
相关论文
共 62 条
[1]   Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors [J].
Afzelius, L ;
Zamora, I ;
Masimirembwa, CM ;
Karlén, A ;
Andersson, TB ;
Mecucci, S ;
Baroni, M ;
Cruciani, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (04) :907-914
[2]   Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors [J].
Afzelius, L ;
Masimirembwa, CM ;
Karlén, A ;
Andersson, TB ;
Zamora, I .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (07) :443-458
[3]  
Brosen K, 1995, Clin Pharmacokinet, V29 Suppl 1, P20
[4]   A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries [J].
Chohan, KK ;
Paine, SW ;
Mistry, J ;
Barton, P ;
Davis, AM .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (16) :5154-5161
[5]   Novel approach to predicting P450-mediated drug metabolism: Development of a combined protein and pharmacophore model for CYP2D6 [J].
de Groot, MJ ;
Ackland, MJ ;
Horne, VA ;
Alex, AA ;
Jones, BC .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (09) :1515-1524
[6]  
EBNER T, 1993, MOL PHARMACOL, V43, P649
[7]  
Ekins S, 1999, J PHARMACOL EXP THER, V288, P21
[8]   Generation and validation of rapid computational filters for CYP2D6 and CYP3A4 [J].
Ekins, S ;
Berbaum, J ;
Harrison, RK .
DRUG METABOLISM AND DISPOSITION, 2003, 31 (09) :1077-1080
[9]  
Ekins S, 1999, J PHARMACOL EXP THER, V291, P424
[10]  
Ekins S, 1999, J PHARMACOL EXP THER, V290, P429